Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Acq - Fin | Alive

About Mehilainen

Mehilainen is a social and healthcare services business that provides a full range of healthcare services from primary care to secondary care through a network of hospitals, outpatient, and dental clinics. It is based in Helsinki, Finland.

Mehilainen Headquarters Location

Pohjoinen Hesperiankatu 17 C

Helsinki, 00260,


+358 0104140112

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Mehilainen News

Sorainen and Ellex Raidla Advise on Mehilainen's Acquisition of Qvalitas Arstikeskus and Unimed Grupp from BaltCap

Mar 12, 2021

Latest In-House Deal 5: Van der Vorm Vastgoed's Margreet van der Vorm and Rene Voortmeijer on La Praga Acquisition in Warsaw Details Details 12 March 2021 Share This Sorainen has advised Mehilainen, a healthcare and social services provider in Finland, on the acquisition of occupational healthcare provider Qvalitas Arstikeskus and dental care chain Unimed Grupp from BaltCap. Ellex Raidla advised BaltCap on the deal, which remains contingent on regulatory approval. According to Sorainen, “the new strategic owner will continue under the same brand and with the same board in both organizations.” Sorainen’s Estonian team was led by Partner Piret Jesse and Senior Associate Piret Lappert and included Counsel Pirkko-Liis Harkmaa, Senior Associates Kaido Kunnapas, Piibe Lehtsaar, Britta Retel, Lise-Lotte Laane, Robin Teever, Monika Tomberg, and Mirjam Vichmann, Associates Liisa Maria Kuuskmaa and Katlin Helena Sehver, and Legal Assistant Kadri Puu. Ellex Raidla's team was led by Partner Ermo Kosk and Senior Associate Sandra Vark and included Managing Partner Ants Nomper, Partners Gerli Kivisoo and Martin Maesalu, Counsels Toomas Kasesalu and Dmitri Rozenblat, Senior Associates Maria Teder, Julia Kisseljova, Hanna Pahk, and Anneli Krunks, and Associates Kevin Gerretz, Merlin Liis, and Kairi Kilgi.

Mehilainen Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Mehilainen Rank

  • When was Mehilainen founded?

    Mehilainen was founded in 1909.

  • Where is Mehilainen's headquarters?

    Mehilainen's headquarters is located at Pohjoinen Hesperiankatu 17 C, Helsinki.

  • What is Mehilainen's latest funding round?

    Mehilainen's latest funding round is Acq - Fin.

  • Who are the investors of Mehilainen?

    Investors of Mehilainen include CVC Capital Partners, LocalTapiola Pension, Ilmarinen Pension Insurance, Varma Mutual Pension Insurance Company, KKR and 3 more.

  • Who are Mehilainen's competitors?

    Competitors of Mehilainen include Steripolar.

You May Also Like

Mediq Logo

Mediq is an international provider of medical devices, pharmaceuticals and the associated care. Mediq takes care of the delivery from supplier to patient, via 3 distribution channels: directly to people's homes, if needed with the associated care; via healthcare professionals such as hospitals; and via Mediq Apotheken (pharmacies). Mediq is listed on NYSE Euronext Amsterdam.In September 2012, Mediq was acquired by Advent International. The valuation of Mediq was $1 billion. Other terms of the deal were not released.

UPM Biomedicals

UPM Biomedicals develops and supplies sustainable wood-based biomedical products for a variety of uses. Its high-quality products are derived from renewable wood sources originating from sustainably managed and certified forests.


Steripolar offers medical technology, new treatments for patient care, high-quality durables, medical devices, and capital equipment to public health care and privately owned health care sector in Finland. The company enables successful patient care by working closely with the manufacturers of health care products.


BICO is a bio convergence company. With a focus on the application areas of bioprinting, cell line development, and diagnostics, the company develops and markets innovative technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. It is based in Gothenburg, Sweden.

Pihlajalinna Logo

Pihlajalinna (HEL: PIHLIS) provides social and healthcare services for households, companies, insurance companies, and public sector entities in private clinics, health centers, dental clinics, and hospitals around Finland. Pihlajalinna provides general practitioner and specialized care services, including emergency and on-call services, a wide range of surgical services, occupational healthcare, and dental care services, in private clinics and hospitals operating under the Dextra brand. Under the Pihlajalinna brand the Company, in cooperation with the public sector, offers social and healthcare service provision models to public sector entities with the aim of providing high-quality services for public pay healthcare customers.

Terveystalo Logo

Terveystalo (HEL: TTALO) is a Finland-based private healthcare service provider, offering a care package comprising occupational health, primary healthcare, diagnostics, and surgical treatment through its network of private hospitals. The company was founded in 2001 and is based in Helsinki, Finland.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.